Now showing items 1-2 of 2
MeCP2 Deficiency Leads to Loss of Glial Kir4.1
(Society for Neuroscience, 2018)
Rett syndrome is a devastating neurodevelopmental disorder that affects 1 in 10,000–25,000 females. Mutations in methyl-CpG-binding protein 2 (MeCP2), a transcriptional regulator, are responsible for >95% of RTT cases. ...
Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome
Rett syndrome (RTT) is a rare, X-linked neurodevelopmental disorder typically affecting females, resulting in a range of symptoms including autistic features, intellectual impairment, motor deterioration, and autonomic ...